Form D · Other Health Care
PreEmptive Meds, Inc.
Lebanon, NJ · CIK 0001411177
Offering snapshot reported Aug 18, 2010 · SEC filing
- Reported sold
- Yet to sell Offering amount: $500K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 18, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 27, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-146620
Source: Form D, filed Aug 18, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles N. Blitzer | Director, Executive |
| Daniel Einhorn | Director |
| Joseph Fenn | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3 Saxton Lane
Lebanon, NJ, 08833
Lebanon, NJ, 08833